New York State Common Retirement Fund’s Dutch Bros BROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46M Sell
89,927
-17,362
-16% -$996K 0.01% 970
2026
Q1
$5.44M Buy
107,289
+6,516
+6% +$356K 0.01% 990
2025
Q4
$6.17M Buy
100,773
+8,968
+10% +$510K 0.01% 953
2025
Q3
$4.81M Buy
91,805
+600
+0.7% +$37.9K 0.01% 1080
2025
Q2
$6.24M Sell
91,205
-5,657
-6% -$369K 0.01% 979
2025
Q1
$5.98M Sell
96,862
-151,561
-61% -$9.98M 0.01% 966
2024
Q4
$13M Buy
248,423
+4,956
+2% +$219K 0.02% 646
2024
Q3
$7.8M Buy
243,467
+45,965
+23% +$1.62M 0.01% 900
2024
Q2
$8.18M Buy
197,502
+107,699
+120% +$3.7M 0.01% 902
2024
Q1
$2.96M Buy
+89,803
New +$2.65M ﹤0.01% 1315
2022
Q2
Sell
-32,456
Closed -$1.79M 3480
2022
Q1
$1.79M Buy
+32,456
New +$1.66M ﹤0.01% 1803

Other funds holding BROS

New York State Common Retirement Fund's BROS Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Dutch Bros (BROS) stake by 16% in Q2 2026, selling an estimated $996K and leaving 89,927 shares worth $6.46M. The position accounts for 0.01% of the portfolio, ranked #970.

New York State Common Retirement Fund first reported a position in BROS in Q1 2022 and has held it in 11 quarters since. The position peaked at $13M in Q4 2024. 284 funds tracked by Wall St. Rank hold BROS as of Q2 2026.

  • New York State Common Retirement Fund held 89,927 shares of Dutch Bros worth $6.46M as of Q2 2026.
  • New York State Common Retirement Fund sold 17,362 Dutch Bros shares in Q2 2026, an estimated $996K.
  • Dutch Bros made up 0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #970 holding.
  • New York State Common Retirement Fund first reported a position in Dutch Bros in Q1 2022 and has held it in 11 quarters since.
  • New York State Common Retirement Fund's Dutch Bros position peaked at $13M in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Dutch Bros as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.